Navigation Links
UCSD-Salk Team Show Protein’s Gene-Silencing Role In Development of Nervous System

The first evidence that a group of proteins called phosphatases play a key role in the development of the nervous system, has been shown in fruit flies and mice by researchers at the University of California, San Diego (UCSD) School of Medicine, in collaboration with scientists at the Salk Institute, La Jolla, California. The phosphatases are required for maintenance of neural stem cells and for silencing expression of neuronal genes in non-nervous system tissues.

Published in the January 28, 2005 issue of the journal Science, the study found that the phosphatases, called small carboxyl-terminal domain phosphatases (SCPs) are expressed in almost all tissues of the body. In their “on?position, the phosphatases prevent neuronal genes from being expressed in areas of the body, such as the heart and liver, where they shouldn’t be. When these phosphatases are shut off in the nervous system, neuronal stem cells can develop into specialized neurons.

The researchers determined that SCPs are a component of a previously identified master gene complex called REST/NRSF, which is known to control neuronal genes. In their investigations with mice and fruit flies, the scientists found that REST/NRSF recruits SCPs only to neuronal genes.

“These findings suggest a way to expand the pool of neuronal stem cells, which could lead to new therapeutic strategies for neurological disorders,?said the study’s senior author, Gordon Gill, M.D., UCSD professor of medicine.

The ability of SCPs to silence genes was first shown by Gill and his post-doctoral fellow Michele Yeo, Ph.D., in an April 28, 2003 study published in the Journal of Biological Chemistry. Yeo is co-first author of the new study in Science, along with Soo-Kyung Lee, Ph.D., a post-doctoral fellow in the lab of Samuel L. Pfaff, Ph.D., associate professor, Salk Institute. Additional authors are Bora Lee, Ph.D. and Esmeralda C. Ruiz, B.S., Salk Institute.


'"/>

Source:University of California, San Diego


Page: 1

Related biology news :

1. Protein Packages Found To Activate Genes; May Be What Regulates Development And Disease
2. Gene Vaccine Protects Mice Against Development Of Her2/neu Breast Cancer
3. Development of portable infectious disease detector
4. Unexpressed But Indispensable -- The DNA Sequences That Control Development
5. Analysis Of Human Genome To Predict The Development Of Illnesses
6. Development of gene therapy
7. “Hitchhiking?Viruses as Cancer Drug Delivery System
8. Key To Stem Cell Transplant Success Is Tricking Immune System
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/30/2017)... , June 30, 2017 Today, ... developer and supplier of face and eye tracking ... Featured Product provider program. "Artificial ... innovative way to monitor a driver,s attentiveness levels ... from being able to detect fatigue and prevent ...
(Date:5/16/2017)... May 16, 2017  Veratad Technologies, LLC ( www.veratad.com ... age and identity verification solutions, announced today they will ... 2017, May 15 thru May 17, 2017, in ... International Trade Center. Identity impacts the ... in today,s quickly evolving digital world, defining identity is ...
(Date:4/19/2017)... ALBANY, New York , April 19, 2017 /PRNewswire/ ... highly competitive, as its vendor landscape is marked by ... in the market is however held by five major ... and Safran. Together these companies accounted for nearly 61% ... majority of the leading companies in the global military ...
Breaking Biology News(10 mins):
(Date:7/20/2017)... ... , ... Dr. Asher Kimchi, Founder and Chairman of the International Academy ... the 22nd World Congress on Heart Disease held in Vancouver, BC, Canada. In addition ... Fellowship Awards. , Dr. Asher Kimchi, together with Co-Chairmen Dr. John A. Elefteriades and ...
(Date:7/20/2017)... , ... July 20, 2017 , ... VIC Technology ... joining the company’s board of directors. This addition continues to strengthen and diversify ... Calvin Goforth, CEO and Chairman. “He is a highly accomplished business executive with a ...
(Date:7/20/2017)... 20, 2017   KCNQ2 Cure Alliance  and ... company, today announced that they have completed the ... mutation implicated in KCNQ2 epileptic encephalopathy. They also ... second case involving an additional KCNQ2 genetic mutation. ... and Pairnomix entered into a collaboration to further ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... solution to make clinical trial sites and study participants truly unified. TrialKit, a ... compliant (FDA 21 CFR Part 11) research studies entirely on mobile devices. With ...
Breaking Biology Technology: